Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation

References

• Kumar S, DeLeve LD, Kamath PS, et al. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 2003;78:589-98
   PubMed Web of Science ®Google Scholar
• Berk PD, Popper H, Krueger GR, et al. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation: possible association with graft-versus-host disease. Ann Intern Med 1979;90:158-64
   PubMed Web of Science ®Google Scholar
• Jacobs P, Miller JL, Uys CJ, et al. Fatal veno-occlusive disease of the liver after chemotherapy, whole-body irradiation and bone marrow transplantation for refractory acute leukaemia. S Afr Med J 1979;55:5-10
   PubMed Web of Science ®Google Scholar
• Harper JL. Veno-occlusive hepatic disease. 2016. http://emedicine.medscape.com/article/989167-overview. [Last accessed 7 November 2016]
   Google Scholar
• Coppell JA, Richardson PG, Soiffer R, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 2010;16:157-68
   PubMed Web of Science ®Google Scholar
• Strouse C, Richardson P, Prentice G, et al. Defibrotide for treatment of severe veno-occlusive disease in pediatrics and adults: an exploratory analysis using data from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 2016;22:1306-12
   PubMed Web of Science ®Google Scholar
• Richardson PG, Ho VT, Giralt S, et al. Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease. Ther Adv Hematol 2012;3:253-65
   PubMedGoogle Scholar
• Harper JL. Veno-occlusive hepatic disease clinical presentation. 2016. http://emedicine.medscape.com/article/989167-clinical. [Last accessed 7 November 2016]
   Google Scholar
• Lee SH, Yoo KH, Sung KW, et al. Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Bone Marrow Transplant 2010;45:1287-93
   PubMed Web of Science ®Google Scholar
• Carreras E, Díaz-Beyá M, Rosiñol L, et al. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant 2011;17:1713-20
   PubMed Web of Science ®Google Scholar
• Khera N, Zeliadt SB, Lee SJ. Economics of hematopoietic cell transplantation. Blood 2012;120:1545-51
   PubMed Web of Science ®Google Scholar
• Lee SJ, Klar N, Weeks JC, et al. Predicting costs of stem-cell transplantation. J Clin Oncol 2000;18:64-71
   PubMed Web of Science ®Google Scholar
• Svahn BM, Alvin O, Ringdén O, et al. Costs of allogeneic hematopoietic stem cell transplantation. Transplantation 2006;82:147-53
   PubMed Web of Science ®Google Scholar
• Majhail NS, Mothukuri JM, Brunstein CG, et al. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications. Biol Blood Marrow Transplant 2009;15:564-73
   PubMed Web of Science ®Google Scholar
• Svahn BM, Remberger M, Alvin O, et al. Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation. Bone Marrow Transplant 2012;47:706-15
   PubMed Web of Science ®Google Scholar
• McDonald GB, Sharma P, Matthews DE, et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984;4:116-22
   PubMed Web of Science ®Google Scholar
• Jones RJ, Lee KS, Beschorner WE, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987;44:778-83
   PubMed Web of Science ®Google Scholar
• Mohty M, Malard F, Abecassis M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 2016;51:906-12
   PubMed Web of Science ®Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
   PubMed Web of Science ®Google Scholar
• Weichle T, Hynes DM, Durazo-Arvizu R, et al. Impact of alternative approaches to assess outlying and influential observations on health care costs. Springerplus 2013;2:614
   PubMed Web of Science ®Google Scholar
• Li Z, Mahendra G. Using “recycled predictions” for computing marginal effects, statistics and data analysis. SAS Global Forum; 2010, Paper 272–2010. http://support.sas.com/resources/papers/proceedings10/272-2010.pdf. [Last access 20 October 2016]
   Google Scholar
• Saito AM, Cutler C, Zahrieh D, et al. Costs of allogeneic hematopoietic cell transplantation with high-dose regimens. Biol Blood Marrow Transplant 2008;14:197-207
   PubMed Web of Science ®Google Scholar
• Tsirigotis PD, Resnick IB, Avni B, et al. Incidence and risk factors for moderate-to-severe veno-occlusive disease of the liver after allogeneic stem cell transplantation using a reduced intensity conditioning regimen. Bone Marrow Transplant 2014;49:1389-92
   PubMed Web of Science ®Google Scholar
• Pastores SM, Papadopoulos E, van den Brink M, et al. Septic shock and multiple organ failure after hematopoietic stem cell transplantation: treatment with recombinant human activated protein C. Bone Marrow Transplant 2002;30:131-4
   PubMed Web of Science ®Google Scholar
• Kumar G, Ahmad S, Taneja A, et al. Severe sepsis in hematopoietic stem cell transplant recipients. Crit Care Med 2015;43:411-21
   PubMed Web of Science ®Google Scholar
• Espérou H, Brunot A, Roudot-Thoraval F, et al Predicting the costs of allogeneic sibling stem-cell transplantation: results from a prospective, multicenter, French study. Transplantation 2004;77:1854-8
   PubMed Web of Science ®Google Scholar
• Stranges E, Russo CA, Friedman B. Procedures with the most rapidly increasing hospital costs, 2004–2007. HCUP Statistical Brief #82. Rockville, MD: Agency for Healthcare Research and Quality; 2009. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb82.pdf [Last accessed 20 October 2016]
   Google Scholar
• Cesaro S, Pillon M, Talenti E, et al. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica 2005;90:1396-404
   PubMed Web of Science ®Google Scholar
• Mohty M, Malard F, Abecassis M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 2016;51:906-12
   PubMed Web of Science ®Google Scholar
• Dignan FL, Wynn RF, Hadzic N, et al. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol 2013;163:444-57
   PubMed Web of Science ®Google Scholar
• Majhail NS, Mau LW, Denzen EM, et al. Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large national private claims database. Bone Marrow Transplant 2013;48:294-300
   PubMed Web of Science ®Google Scholar